Vanda Pharmaceuticals Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
VNDA on Nasdaq
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC

Insiders trading volume in the past year

Vanda Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mihael H. Polymeropoulos President and CEO, Director, Chairman of the Board $7.73M -$231K -2.91% Mar 4, 2024
Kevin Patrick Moran SVP, CFO & Treasurer $1.36M -$76.7K -5.35% Jul 29, 2024
Gunther Birznieks SVP, Business Development $1.3M -$73.4K -5.36% Mar 4, 2024
Timothy Williams SVP & General Counsel $823K -$73.3K -8.18% Mar 4, 2024
Joakim Wijkstrom SVP, Chief Marketing Officer $546K -$71.9K -11.6% Mar 4, 2024
Richard W. Dugan Director $494K May 17, 2024
Aranthan Jones II Chief Corp. Affairs Officer $479K Sep 15, 2021
Thomas Watkins Director $368K Jun 2, 2022
Tage Honore Director $269K May 17, 2024
Phaedra Chrousos Director $268K May 22, 2024
Anne Sempowski Ward Director $250K May 17, 2024
Stephen Ray Mitchell Director $232K -$25.9K -10% Nov 14, 2024

Recent Insider Transactions by Companies or Individuals for Vanda Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.